The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
PANORAMA1: A randomized, double-blind, placebo controlled phase III study of panobinostat in combination with bortezomib and dexamethasone in patients with relapsed multiple myeloma.
J. F. San-Miguel
Consultant or Advisory Role - Celgene; Janssen Oncology; Millennium; Novartis
Honoraria - Celgene; Janssen Oncology; Millennium; Novartis
S. Lonial
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; Merck; Millennium; Novartis; Onyx
Research Funding - Bristol-Myers Squibb; Celgene; Merck; Millennium; Novartis; Onyx
V. Hungria
No relevant relationships to disclose
P. Moreau
No relevant relationships to disclose
H. Einsele
Consultant or Advisory Role - Celgene; Janssen-Cilag; Mundipharma; Novartis
Research Funding - Celgene; Janssen-Cilag
J. H. Lee
No relevant relationships to disclose
S. Yoon
No relevant relationships to disclose
P. Corradini
Consultant or Advisory Role - Adienne; Novartis
Honoraria - Celgene; Genzyme; Novartis; Roche
W. W. Jedrzejczak
No relevant relationships to disclose
D. C. Tan
Consultant or Advisory Role - Celgene; Janssen-Cilag
Honoraria - Celgene; Janssen-Cilag
Research Funding - Janssen-Cilag; Novartis
K. Yong
No relevant relationships to disclose
A. Guenther
Research Funding - Novartis
Expert Testimony - Celgene; Novartis
M. M. Wroclawska-Swacha
Employment or Leadership Position - Novartis
H. J. Weber
Employment or Leadership Position - Novartis
P. M. Bourquelot
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
P. G. G. Richardson
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; Johnson & Johnson; Millennium; Novartis